<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">evrazkar</journal-id><journal-title-group><journal-title xml:lang="ru">Евразийский Кардиологический Журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Eurasian heart journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2225-1685</issn><issn pub-type="epub">2305-0748</issn><publisher><publisher-name>Евразийская ассоциация кардиологов</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.38109/2225-1685-2011-1-38-45</article-id><article-id custom-type="elpub" pub-id-type="custom">evrazkar-5427</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>СОСТОЯНИЕ ВЕГЕТАТИВНОЙ НЕРВНОЙ СИСТЕМЫ, АКТИВНОСТЬ КАЛЬЦИЕВЫХ КАНАЛОВ, ПОЛИМОРФИЗМ ГЕНОВ АНГИОТЕНЗИНПРЕВРАЩАЮЩЕГО ФЕРМЕНТА И Β2-АДРЕНОРЕЦЕПТОРОВ У БОЛЬНЫХ С ОСЛОЖНЕННЫМ ТЕЧЕНИЕМ ЭССЕНЦИАЛЬНОЙ ГИПЕРТЕНЗИИ</article-title><trans-title-group xml:lang="en"><trans-title>Autonomic nervous system state, calcium channel activity and gene polymorphisms of angiotensin-converting enzyme inhibitor and β2-adrenergic receptor in patients with complicated essential arterial hypertension</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Джумагулова</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Jumagulova</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Айнагуль Сексеналиевна Джумагулова</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полупанов</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Polupanov</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Полупанов Андрей Геннадьевич</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Романова</surname><given-names>Т. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Romanova</surname><given-names>T. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Татьяна Анатольевна Романова</p></bio><email xlink:type="simple">romanova_14@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ческидова</surname><given-names>Н. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Cheskidova</surname><given-names>N. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ческидова Наталья Борисовна</p></bio><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Национальный центр кардиологии и терапии им. академика М.М.Миррахимова при МЗ</institution><country>Kyrgyzstan</country></aff><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>30</day><month>03</month><year>2011</year></pub-date><volume>0</volume><issue>1</issue><fpage>38</fpage><lpage>45</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Джумагулова А.С., Полупанов А.Г., Романова Т.А., Ческидова Н.Б., 2011</copyright-statement><copyright-year>2011</copyright-year><copyright-holder xml:lang="ru">Джумагулова А.С., Полупанов А.Г., Романова Т.А., Ческидова Н.Б.</copyright-holder><copyright-holder xml:lang="en">Jumagulova A.S., Polupanov A.G., Romanova T.A., Cheskidova N.B.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.heartj.asia/jour/article/view/5427">https://www.heartj.asia/jour/article/view/5427</self-uri><abstract><p>Цель исследования: изучение состояния вегетативной нервной системы (ВНС), полиморфизма генов ангиотензин-превращающего фермента (АПФ) и β2-адренорецепторов, а также внутриклеточного обмена кальция у больных эссенциальной гипертензией (ЭГ) с осложненным течением заболевания (при развитии гипертрофии левого желудочка (ГЛЖ) и ишемического инсульта). Материалы и методы: Обследовано 250 мужчин этнических кыргызов, страдающих ЭГ, среди них 180 больных, не имеющих в анамнезе острых нарушений мозгового кровообращения, 70 пациентов, перенесших ишемический инсульт и 35 больных с ГЛЖ. Группа контроля - 19 здоровых лиц. Проводилось суточное мониторирование АД, эхокардиографическое и допплерэхокардиографическое исследование, дуплексное сканирование сонных артерий, активность кальциевых каналов, спектральный анализ вариабельности сердечного ритма (ВСР) с применением активного тилт-теста и определение полиморфизмов гена АПФ и β2-адренорецепторов. Результаты: У больных ЭГ при проведении тилт-теста наблюдается менее выраженный прирост LF-компонента по сравнению со здоровыми лицами, а при наличии осложнений ЭГ отмечается не возрастание, а, напротив, снижение мощности LF-колебаний. Выявлена гиперактивность АТФ/АДФ зависимых кальциевых каналов в тромбоцитах у больных ЭГ при развитии ГЛЖ. Для больных ЭГ с Gln27Gln генотипом в отличие от больных, имеющих другие варианты гена в2-адренорецепторов характерны более высокие уровни среднесуточных значений АД с ускоренным его подъемом в утренние часы. У больных ЭГ обнаружена ассоциация I/D полиморфизма гена АПФ с наличием ишемического инсульта. При этом носительство DD генотипа является независимым от нарушений суточной ритмики АД и толщины КИМ предиктором развития ишемического инсульта у больных ЭГ. Заключение: Предложены некоторые возможные клинические и генетические предикторы осложненного течения ЭГ (ригидная реакция LF-компонента ВСР при проведении тилт-теста, наличие гиперактивности кальциевых каналов, носительство Gln27Gln генотипа β2-адренорецепторов и I/D полиморфизма гена АПФ).</p></abstract><trans-abstract xml:lang="en"><p>Objective: to study the state of the autonomic nervous system (ANS), gene polymorphism of angiotensin-converting enzyme (ACE) and β2-adrenergic receptors, and intracellular calcium metabolism in patients with essential hypertension (EH) with a complicated course of the disease (left ventricular hypertrophy (LVH ) and ischemic stroke). Materials and methods: A total of 250 Kirgiz male with EH, among them 180 patients without stroke, 70 patients who had ischemic stroke and 35 patients with LVH were examined. Control group -19 healthy peoples. It were performed daily blood pressure monitoring, echocardiography, duplex scanning of carotid arteries, the activity of calcium channels, spectral analysis of heart rate variability (HRV) during active tilt-test and genotyping on ACE and the β2-adrenergic receptors. Results: It was observed a significant reduction of HRV and decreased response of LF (low frequency) component to tilt-test in hypertensive patients, compared to control. Tilt-test in patients with complications of EH had shown inverse response of LF to orthostatic test. It was found hyperactivity of ATP/ADP dependent calcium channels in platelets in patients with EH during the development of LVH. Patients with Gln27Gln genotype in compare to other variants of Gln27Glu polymorphism of β2-AR were characterized by increasing meanings of BP and its morning raises which possibly may cause increasing of left ventricular mass in these patients. 3. Our data support an association between I/D polymorphism and stroke in patients with EH. Presence of DD genotype may be considered as independent from daily profile of BP and intima-media thickness predictor of ischemic stroke in patients with EH. Conclusion: We propose several possible clinical and genetic predictors of complicated EH (rigid response of LF-component during tilt-test, the presence of hyperactivity calcium channel, carrier of Gln27Gln polymorphism of β2-adrenergic receptors and I/D polymorphism of ACE gene).</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эссенциальная гипертензия</kwd><kwd>вариабельность сердечного ритма</kwd><kwd>кальциевые каналы</kwd><kwd>гипертрофия левого желудочка</kwd><kwd>инсульт</kwd><kwd>гены</kwd><kwd>essential hypertension</kwd><kwd>heart rate variability</kwd><kwd>calcium channels</kwd><kwd>left ventricular hypertrophy</kwd><kwd>stroke</kwd><kwd>genes</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">JNC 7 Express. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute. National High Blood Pressure Education Program. NIH Publication No. 03-5233. May 2003.</mixed-citation><mixed-citation xml:lang="en">JNC 7 Express. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. U.S. Department of Health and Human Services. National Institutes of Health. National Heart, Lung, and Blood Institute. National High Blood Pressure Education Program. NIH Publication No. 03-5233. May 2003.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Vakili B., Okin P., Devereux R. Prognostic implications of left ventricular hypertrophy. Am. Heart J. 2001; 141:334-341.</mixed-citation><mixed-citation xml:lang="en">Vakili B., Okin P., Devereux R. Prognostic implications of left ventricular hypertrophy. Am. Heart J. 2001; 141:334-341.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Koren M., Richard B., Devereux M. et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann. Intern. Med. 1991; 114:345-352.</mixed-citation><mixed-citation xml:lang="en">Koren M., Richard B., Devereux M. et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann. Intern. Med. 1991; 114:345-352.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Levy D., Garrison R., Savage D. et al. Prognostic implications of echocardiographically - determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 1990; 322:1561-1566.</mixed-citation><mixed-citation xml:lang="en">Levy D., Garrison R., Savage D. et al. Prognostic implications of echocardiographically - determined left ventricular mass in the Framingham Heart Study. N. Engl. J. Med. 1990; 322:1561-1566.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization, Regional Office for Europe. European health for all databases (HFA-DB), 2006.</mixed-citation><mixed-citation xml:lang="en">World Health Organization, Regional Office for Europe. European health for all databases (HFA-DB), 2006.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kalmyrzaev B., Aldashev A., Khalmatov M., Polupanov A., Jumagulova A., Mamanova L., Wilkins M., Town M. A Genome-Wide Scan for Premature Hypertension Supports Linkage to Chromosome 2 in a Large Kyrgyz Family. Hypertension 2006; 48(5): 908-913.</mixed-citation><mixed-citation xml:lang="en">Kalmyrzaev B., Aldashev A., Khalmatov M., Polupanov A., Jumagulova A., Mamanova L., Wilkins M., Town M. A Genome-Wide Scan for Premature Hypertension Supports Linkage to Chromosome 2 in a Large Kyrgyz Family. Hypertension 2006; 48(5): 908-913.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zee R.Y., Ridker P.M. et.al. Prospective evaluation of the angiotensin-converting enzyme insertion/ deletion polymorphism and the risk of stroke. Circulation 1999; 99:340-343.</mixed-citation><mixed-citation xml:lang="en">Zee R.Y., Ridker P.M. et.al. Prospective evaluation of the angiotensin-converting enzyme insertion/ deletion polymorphism and the risk of stroke. Circulation 1999; 99:340-343.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Squire I.B., Reid J.L. Interactions between reninangiotensin system and autonomic nervous system. In Robertson JLS. The Renin Angiotensin System. London: Gower, 1993.</mixed-citation><mixed-citation xml:lang="en">Squire I.B., Reid J.L. Interactions between reninangiotensin system and autonomic nervous system. In Robertson JLS. The Renin Angiotensin System. London: Gower, 1993.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Grien K.K., Murphy T.J., Alexander R.W. Molecular biology of the renin-angiotensin system. Circulation 1993; 87: 1816-1828.</mixed-citation><mixed-citation xml:lang="en">Grien K.K., Murphy T.J., Alexander R.W. Molecular biology of the renin-angiotensin system. Circulation 1993; 87: 1816-1828.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Esler M. Sympathetic activity in experimental and human hypertension. In Mancia G edc. Handbook of hypertension 1997; 17:628-673.</mixed-citation><mixed-citation xml:lang="en">Esler M. Sympathetic activity in experimental and human hypertension. In Mancia G edc. Handbook of hypertension 1997; 17:628-673.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Simpson P.S., Kariya K., Karns L.R. et al. Adrenergic hormones and control of cardiac myocyte growth. Mol. Cell. Biochem. 1991; 104:35-43.</mixed-citation><mixed-citation xml:lang="en">Simpson P.S., Kariya K., Karns L.R. et al. Adrenergic hormones and control of cardiac myocyte growth. Mol. Cell. Biochem. 1991; 104:35-43.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Leineweber K. Beta-adrenergic receptor polymorphism in human cardiovascular disease. Ann. Med. 2004; 36:64-69.</mixed-citation><mixed-citation xml:lang="en">Leineweber K. Beta-adrenergic receptor polymorphism in human cardiovascular disease. Ann. Med. 2004; 36:64-69.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Duner E. et al. Intracellular free calcium abnormalities in fibroblasts from no-insulin dependent diabetic patients with without arterial hypertension. Hypertension 1997; 29(4): 1007-13.</mixed-citation><mixed-citation xml:lang="en">Duner E. et al. Intracellular free calcium abnormalities in fibroblasts from no-insulin dependent diabetic patients with without arterial hypertension. Hypertension 1997; 29(4): 1007-13.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Орлов С.Н., Покудин Н.И., Постнов Ю.В. Внутриклеточная концентрация свободного кальция в тромбоцитах: особенности, выявляемые при спонтанной гипертензии. Кардиология 1984; 4:93-98.</mixed-citation><mixed-citation xml:lang="en">Орлов С.Н., Покудин Н.И., Постнов Ю.В. Внутриклеточная концентрация свободного кальция в тромбоцитах: особенности, выявляемые при спонтанной гипертензии. Кардиология 1984; 4:93-98.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Gruska S. et al. Prevalenceof increased intracellular signal transduction in immortalized lymphoblasts from patients with arterial hypertension and normotensive subjects. J of Hypertension 1997; 15(1): 29-33.</mixed-citation><mixed-citation xml:lang="en">Gruska S. et al. Prevalenceof increased intracellular signal transduction in immortalized lymphoblasts from patients with arterial hypertension and normotensive subjects. J of Hypertension 1997; 15(1): 29-33.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
